Logo image of ASLE

AERSALE CORP (ASLE) Stock Fundamental Analysis

USA - NASDAQ:ASLE - US00810F1066 - Common Stock

8.66 USD
+0.33 (+3.96%)
Last: 9/18/2025, 5:24:00 PM
8.49 USD
-0.17 (-1.96%)
After Hours: 9/18/2025, 5:24:00 PM
Fundamental Rating

5

Overall ASLE gets a fundamental rating of 5 out of 10. We evaluated ASLE against 69 industry peers in the Aerospace & Defense industry. The financial health of ASLE is average, but there are quite some concerns on its profitability. ASLE is evaluated to be cheap and growing strongly. This does not happen too often!


Dividend Valuation Growth Profitability Health

3

1. Profitability

1.1 Basic Checks

ASLE had positive earnings in the past year.
In the past year ASLE had a positive cash flow from operations.
Of the past 5 years ASLE 4 years were profitable.
The reported operating cash flow has been mixed in the past 5 years: ASLE reported negative operating cash flow in multiple years.
ASLE Yearly Net Income VS EBIT VS OCF VS FCFASLE Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2018 2019 2020 2021 2022 2023 2024 0 50M -50M -100M -150M

1.2 Ratios

With a Return On Assets value of 1.01%, ASLE perfoms like the industry average, outperforming 46.38% of the companies in the same industry.
ASLE has a Return On Equity (1.56%) which is comparable to the rest of the industry.
ASLE's Return On Invested Capital of 1.70% is in line compared to the rest of the industry. ASLE outperforms 43.48% of its industry peers.
Industry RankSector Rank
ROA 1.01%
ROE 1.56%
ROIC 1.7%
ROA(3y)2.74%
ROA(5y)3.56%
ROE(3y)3.3%
ROE(5y)4.23%
ROIC(3y)N/A
ROIC(5y)N/A
ASLE Yearly ROA, ROE, ROICASLE Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2018 2019 2020 2021 2022 2023 2024 0 2 4 6 8

1.3 Margins

ASLE has a Profit Margin (1.86%) which is comparable to the rest of the industry.
ASLE's Profit Margin has declined in the last couple of years.
ASLE has a Operating Margin (3.65%) which is comparable to the rest of the industry.
In the last couple of years the Operating Margin of ASLE has declined.
The Gross Margin of ASLE (30.44%) is better than 68.12% of its industry peers.
In the last couple of years the Gross Margin of ASLE has declined.
Industry RankSector Rank
OM 3.65%
PM (TTM) 1.86%
GM 30.44%
OM growth 3Y-38.78%
OM growth 5YN/A
PM growth 3Y-45.72%
PM growth 5YN/A
GM growth 3Y-4.95%
GM growth 5YN/A
ASLE Yearly Profit, Operating, Gross MarginsASLE Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2018 2019 2020 2021 2022 2023 2024 0 10 20 30

4

2. Health

2.1 Basic Checks

The Return on Invested Capital (ROIC) is below the Cost of Capital (WACC), so ASLE is destroying value.
Compared to 1 year ago, ASLE has more shares outstanding
Compared to 5 years ago, ASLE has more shares outstanding
The debt/assets ratio for ASLE has remained at the same level compared to a year ago.
ASLE Yearly Shares OutstandingASLE Yearly Shares OutstandingYearly Shares Outstanding 2018 2019 2020 2021 2022 2023 2024 10M 20M 30M 40M 50M
ASLE Yearly Total Debt VS Total AssetsASLE Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M

2.2 Solvency

ASLE has an Altman-Z score of 2.39. This is not the best score and indicates that ASLE is in the grey zone with still only limited risk for bankruptcy at the moment.
With a Altman-Z score value of 2.39, ASLE is not doing good in the industry: 63.77% of the companies in the same industry are doing better.
ASLE has a debt to FCF ratio of 9.61. This is a negative value and a sign of low solvency as ASLE would need 9.61 years to pay back of all of its debts.
ASLE has a Debt to FCF ratio (9.61) which is comparable to the rest of the industry.
A Debt/Equity ratio of 0.28 indicates that ASLE is not too dependend on debt financing.
ASLE has a Debt to Equity ratio of 0.28. This is in the better half of the industry: ASLE outperforms 66.67% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.28
Debt/FCF 9.61
Altman-Z 2.39
ROIC/WACC0.17
WACC10.17%
ASLE Yearly LT Debt VS Equity VS FCFASLE Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2018 2019 2020 2021 2022 2023 2024 0 200M 400M

2.3 Liquidity

ASLE has a Current Ratio of 3.87. This indicates that ASLE is financially healthy and has no problem in meeting its short term obligations.
Looking at the Current ratio, with a value of 3.87, ASLE belongs to the top of the industry, outperforming 82.61% of the companies in the same industry.
A Quick Ratio of 0.82 indicates that ASLE may have some problems paying its short term obligations.
ASLE's Quick ratio of 0.82 is on the low side compared to the rest of the industry. ASLE is outperformed by 76.81% of its industry peers.
Industry RankSector Rank
Current Ratio 3.87
Quick Ratio 0.82
ASLE Yearly Current Assets VS Current LiabilitesASLE Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2018 2019 2020 2021 2022 2023 2024 100M 200M 300M

7

3. Growth

3.1 Past

ASLE shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 300.00%, which is quite impressive.
ASLE shows a strong growth in Earnings Per Share. Measured over the last years, the EPS has been growing by 22.36% yearly.
ASLE shows a decrease in Revenue. In the last year, the revenue decreased by -1.12%.
The Revenue has been growing slightly by 0.45% on average over the past years.
EPS 1Y (TTM)300%
EPS 3Y-40.01%
EPS 5Y22.36%
EPS Q2Q%500%
Revenue 1Y (TTM)-1.12%
Revenue growth 3Y0.45%
Revenue growth 5YN/A
Sales Q2Q%39.27%

3.2 Future

The Earnings Per Share is expected to grow by 87.10% on average over the next years. This is a very strong growth
The Revenue is expected to grow by 13.65% on average over the next years. This is quite good.
EPS Next Y155%
EPS Next 2Y88.94%
EPS Next 3Y87.1%
EPS Next 5YN/A
Revenue Next Year8.81%
Revenue Next 2Y8.48%
Revenue Next 3Y13.65%
Revenue Next 5YN/A

3.3 Evolution

The EPS growth rate is accelerating: in the next years the growth will be better than in the last years.
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
ASLE Yearly Revenue VS EstimatesASLE Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2020 2021 2022 2023 2024 2025 2026 2027 100M 200M 300M 400M 500M
ASLE Yearly EPS VS EstimatesASLE Yearly EPS VS EstimatesYearly EPS VS Estimates 2020 2021 2022 2023 2024 2025 2026 2027 0.2 0.4 0.6 0.8 1

7

4. Valuation

4.1 Price/Earnings Ratio

A Price/Earnings ratio of 30.93 indicates a quite expensive valuation of ASLE.
75.36% of the companies in the same industry are more expensive than ASLE, based on the Price/Earnings ratio.
The average S&P500 Price/Earnings ratio is at 27.20. ASLE is around the same levels.
Based on the Price/Forward Earnings ratio of 12.77, the valuation of ASLE can be described as correct.
Based on the Price/Forward Earnings ratio, ASLE is valued cheaply inside the industry as 97.10% of the companies are valued more expensively.
ASLE is valuated rather cheaply when we compare the Price/Forward Earnings ratio to 22.70, which is the current average of the S&P500 Index.
Industry RankSector Rank
PE 30.93
Fwd PE 12.77
ASLE Price Earnings VS Forward Price EarningsASLE Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 20 40 60

4.2 Price Multiples

82.61% of the companies in the same industry are more expensive than ASLE, based on the Enterprise Value to EBITDA ratio.
Based on the Price/Free Cash Flow ratio, ASLE is valued cheaply inside the industry as 82.61% of the companies are valued more expensively.
Industry RankSector Rank
P/FCF 33.77
EV/EBITDA 15.79
ASLE Per share dataASLE EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 2 4 6 8

4.3 Compensation for Growth

The low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
A more expensive valuation may be justified as ASLE's earnings are expected to grow with 87.10% in the coming years.
PEG (NY)0.2
PEG (5Y)1.38
EPS Next 2Y88.94%
EPS Next 3Y87.1%

0

5. Dividend

5.1 Amount

ASLE does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

AERSALE CORP

NASDAQ:ASLE (9/18/2025, 5:24:00 PM)

After market: 8.49 -0.17 (-1.96%)

8.66

+0.33 (+3.96%)

Chartmill FA Rating
GICS SectorIndustrials
GICS IndustryGroupCapital Goods
GICS IndustryAerospace & Defense
Earnings (Last)08-06 2025-08-06/amc
Earnings (Next)11-05 2025-11-05/amc
Inst Owners52.15%
Inst Owner Change0.76%
Ins Owners8.83%
Ins Owner Change18.71%
Market Cap408.58M
Analysts45.71
Price Target7.14 (-17.55%)
Short Float %3.79%
Short Ratio2.72
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)197.96%
Min EPS beat(2)-157.67%
Max EPS beat(2)553.6%
EPS beat(4)1
Avg EPS beat(4)91.87%
Min EPS beat(4)-157.67%
Max EPS beat(4)553.6%
EPS beat(8)2
Avg EPS beat(8)22.76%
EPS beat(12)3
Avg EPS beat(12)-11.28%
EPS beat(16)7
Avg EPS beat(16)29.34%
Revenue beat(2)1
Avg Revenue beat(2)-3.02%
Min Revenue beat(2)-27.97%
Max Revenue beat(2)21.94%
Revenue beat(4)2
Avg Revenue beat(4)-4.37%
Min Revenue beat(4)-27.97%
Max Revenue beat(4)21.94%
Revenue beat(8)3
Avg Revenue beat(8)-11.05%
Revenue beat(12)3
Avg Revenue beat(12)-14.59%
Revenue beat(16)6
Avg Revenue beat(16)-7.59%
PT rev (1m)7.69%
PT rev (3m)-6.67%
EPS NQ rev (1m)0%
EPS NQ rev (3m)45.83%
EPS NY rev (1m)295.83%
EPS NY rev (3m)-2.06%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)-0.99%
Revenue NY rev (1m)7.26%
Revenue NY rev (3m)7.26%
Valuation
Industry RankSector Rank
PE 30.93
Fwd PE 12.77
P/S 1.17
P/FCF 33.77
P/OCF 18.12
P/B 0.98
P/tB 1.08
EV/EBITDA 15.79
EPS(TTM)0.28
EY3.23%
EPS(NY)0.68
Fwd EY7.83%
FCF(TTM)0.26
FCFY2.96%
OCF(TTM)0.48
OCFY5.52%
SpS7.43
BVpS8.82
TBVpS7.98
PEG (NY)0.2
PEG (5Y)1.38
Profitability
Industry RankSector Rank
ROA 1.01%
ROE 1.56%
ROCE 2.28%
ROIC 1.7%
ROICexc 1.72%
ROICexgc 1.85%
OM 3.65%
PM (TTM) 1.86%
GM 30.44%
FCFM 3.45%
ROA(3y)2.74%
ROA(5y)3.56%
ROE(3y)3.3%
ROE(5y)4.23%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3Y-51.13%
ROICexcg growth 5YN/A
ROICexc growth 3Y-49.58%
ROICexc growth 5YN/A
OM growth 3Y-38.78%
OM growth 5YN/A
PM growth 3Y-45.72%
PM growth 5YN/A
GM growth 3Y-4.95%
GM growth 5YN/A
F-Score6
Asset Turnover0.54
Health
Industry RankSector Rank
Debt/Equity 0.28
Debt/FCF 9.61
Debt/EBITDA 3.62
Cap/Depr 54.75%
Cap/Sales 2.98%
Interest Coverage 1.92
Cash Conversion 70.72%
Profit Quality 185.88%
Current Ratio 3.87
Quick Ratio 0.82
Altman-Z 2.39
F-Score6
WACC10.17%
ROIC/WACC0.17
Cap/Depr(3y)91.07%
Cap/Depr(5y)58.73%
Cap/Sales(3y)3.18%
Cap/Sales(5y)2.2%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)300%
EPS 3Y-40.01%
EPS 5Y22.36%
EPS Q2Q%500%
EPS Next Y155%
EPS Next 2Y88.94%
EPS Next 3Y87.1%
EPS Next 5YN/A
Revenue 1Y (TTM)-1.12%
Revenue growth 3Y0.45%
Revenue growth 5YN/A
Sales Q2Q%39.27%
Revenue Next Year8.81%
Revenue Next 2Y8.48%
Revenue Next 3Y13.65%
Revenue Next 5YN/A
EBIT growth 1Y7673.96%
EBIT growth 3Y-38.5%
EBIT growth 5YN/A
EBIT Next Year219.21%
EBIT Next 3Y99.33%
EBIT Next 5YN/A
FCF growth 1Y106.72%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y113.22%
OCF growth 3Y-47.9%
OCF growth 5YN/A